Sacral Neuromodulation for Male Overactive Bladder
This study is looking at the Axonics SNM System, a device used to treat overactive bladder (OAB) in men. OAB can cause urinary urgency incontinence (UUI), which is a strong, sudden need to urinate that's hard to hold back, or frequent urination (UF). This study is for men aged 18 or older who have OAB, especially those who have had prostate surgery for benign prostatic hyperplasia (BPH) or prostate cancer. Researchers want to see how well the Axonics SNM System works and if it causes any side effects over 6 months and 1 year. The study plans to enroll 150 participants, but its current status is unclear.
- Study design
- This is an interventional study that plans to enroll 150 male participants. It is designed to assess the outcomes of the Axonics SNM System.
- What's involved
- You would need to be able to complete bladder diaries and patient questionnaires, and attend all specified evaluations.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for adverse events and effectiveness for 6 months and 1 year after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
At a glance
Conditions
Where it's being run
22 sites across 16 statesStudy leadership
- Gita Ghadimi, OD · STUDY_DIRECTOR · Boston Scientific Corporation
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Adverse event reporting (Safety)6 months, 1 year
Device related, procedure-related and all serious adverse events
- Performance/Effectiveness - Reduction in UUI or UF episodes6 months, 1 year
Demonstrate a ≥ 50% reduction in the number of UUI or UF episodes on a 3-day diary